NCT03043287View on ClinicalTrials.gov

Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)

CompletedOBSERVATIONAL
Enrollment

420

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

September 9, 2019

Study Completion Date

September 30, 2019

Conditions
Urinary Bladder, Overactive
Interventions
BIOLOGICAL

onabotulinumtoxinA

onabotulinumtoxinA (BOTOX®)100 to 200 U

Trial Locations (3)

21208

Chesapeake Urology Associates, LLC, Baltimore

23235

Virginia Urology, Richmond

71106

Regional Urology, Shreveport

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY